LANCET NEUROLOGY

LANCET NEUROLOGY(英文缩写 LANCET NEUROL),ISSN 1474-4422,eISSN 1474-4465 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。

指标来源：jcr_cas_ifqb

历年影响因子趋势

LANCET NEUROLOGY 最新收录文献

※ 中文译文由 AI 辅助生成,仅供学术参考,请以英文原文为准。

1. Central post-stroke pain: clinical characteristics, pathophysiology, and management. 中风后中枢性疼痛：临床特征、病理生理学和治疗
   Henriette Klit, Nanna B Finnerup, Troels S Jensen
   The Lancet. Neurology 2009 IF: 54.60 Q1 PMID: 19679277

   [中文摘要] 中枢性卒中后疼痛（CPSP）是一种神经性疼痛综合征，可发生在脑血管意外后。这种综合征的特征是与脑血管病变损伤的大脑区域相对应的身体部位的疼痛和感觉异常。CPSP患者疼痛区域出现感觉丧失和超敏反应迹象可能表明了去分化和随后神经元过度兴奋的双重组合。CPSP的确切患病率尚不清楚，部分原因是难以将这种综合征与中风后可能发生的其他疼痛类型（如肩痛、疼痛性痉挛、持续性头痛和其他肌肉骨骼疼痛）区分开来。未来具…

   查看详情 DOI
2. Treatment of hyperkinetic movement disorders.
   Joseph Jankovic
   The Lancet. Neurology 2009 IF: 54.60 Q1 PMID: 19679276

   Parkinson's disease, the most common hypokinetic movement disorder, has received much attention from the clinical and scientific community, but there has been a relative paucity of comprehensive revie…

   查看详情 DOI
3. Focal cortical dysplasia type II: biological features and clinical perspectives.
   Sanjay M Sisodiya, Susanne Fauser, J Helen Cross, Maria Thom
   The Lancet. Neurology 2009 IF: 54.60 Q1 PMID: 19679275

   Focal cortical dysplasia (FCD) type II is an important cause of drug-resistant epilepsy. Clinical presentation is variable, and depends on age of onset of seizures and the location and size of lesion.…

   查看详情 DOI
4. Emerging concepts in neural stem cell research: autologous repair and cell-based disease modelling.
   Philipp Koch, Zaal Kokaia, Olle Lindvall, Oliver Brüstle
   The Lancet. Neurology 2009 IF: 54.60 Q1 PMID: 19679274

   The increasing availability of human pluripotent stem cells provides new prospects for neural-replacement strategies and disease-related basic research. With almost unlimited potential for self-renewa…

   查看详情 DOI
5. Bringing arts-based therapies in from the scientific cold.
   Adrian Burton
   The Lancet. Neurology 2009 IF: 54.60 Q1 PMID: 19679272
   查看详情 DOI
6. Clinical trials and methodological problems in prion diseases.
   Maria Puopolo, Maurizio Pocchiari, Carlo Petrini
   The Lancet. Neurology 2009 IF: 54.60 Q1 PMID: 19679270
   查看详情 DOI
7. Genetic testing for disease susceptibility: a risky business.
   The Lancet. Neurology 2009 IF: 54.60 Q1 PMID: 19679269
   查看详情 DOI
8. Same, better, or worse? Neurocognitive effects of radiotherapy for low-grade gliomas remain unknown.
   Paul D Brown, Jane H Cerhan
   The Lancet. Neurology 2009 IF: 54.60 Q1 PMID: 19665932
   查看详情 DOI
9. Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up.
   Linda Douw, Martin Klein, Selene Saa Fagel, Josje van den Heuvel, Martin Jb Taphoorn, Neil K Aaronson
   The Lancet. Neurology 2009 IF: 54.60 Q1 PMID: 19665931

   Our previous study on cognitive functioning among 195 patients with low-grade glioma (LGG) a mean of 6 years after diagnosis suggested that the tumour itself, rather than the radiotherapy used to trea…

   查看详情 DOI
10. Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study.
    Mikael Mazighi, Jean-Michel Serfaty, Julien Labreuche, Jean-Pierre Laissy, Elena Meseguer, Philippa C Lavallée
    The Lancet. Neurology 2009 IF: 54.60 Q1 PMID: 19647488

    The efficacy of intravenous (IV) alteplase is restricted by the speed of recanalisation and the site of the occlusion. The aim of this study was to ascertain the effect of a combined IV-endovascular a…

    查看详情 DOI